Innovative therapies days – 10&11 October 2024 – Besanรงon, France

10/10/2024 - 11/10/2024
Milan, Italy

Innovative Therapies Days is the key symposium that will give a large part to exchanges between experts in their field: ๐ฌ๐œ๐ข๐ž๐ง๐ญ๐ข๐ฌ๐ญ๐ฌ, ๐œ๐ฅ๐ข๐ง๐ข๐œ๐ข๐š๐ง๐ฌ, ๐š๐ง๐ ๐ข๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ข๐š๐ฅ ๐ฉ๐š๐ซ๐ญ๐ง๐ž๐ซ๐ฌ. You will find them through an ๐„๐ฑ๐ก๐ข๐›๐ข๐ญ๐จ๐ซ ๐•๐ข๐ฅ๐ฅ๐š๐ ๐ž, ๐๐Ÿ๐ ๐ฌ๐ž๐ฌ๐ฌ๐ข๐จ๐ง๐ฌ, ๐š๐ง๐ ๐๐ข๐ฌ๐œ๐ฎ๐ฌ๐ฌ๐ข๐จ๐ง ๐ญ๐ข๐ฆ๐ž๐ฌ and discover their latest scientific progress on CAR-T cells, cell therapies, and cell-derived innovative therapies. While the Bourgogne-Franche-Comtรฉ region is the birthplace of microtechnology, it is the combination of those technologies with cell therapies that enabled the RIGHT institute to bring out flagship products like CAR-T cells! With some national partners and international partners and around 600 visitors, ITD brings together ๐ฌ๐œ๐ข๐ž๐ง๐ญ๐ข๐ฌ๐ญ๐ฌ, ๐œ๐ฅ๐ข๐ง๐ข๐œ๐ข๐š๐ง๐ฌ, ๐š๐ง๐ ๐ข๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ข๐š๐ฅ ๐ฉ๐š๐ซ๐ญ๐ง๐ž๐ซ๐ฌ for 2 days of high-level conferences about CAR-T cells, cell therapies, cell-derived innovative therapies and regulation, production, and clinical transfer of innovative therapies.

  • CAR-T CELLS AND BEYOND

Among recent medical innovations, CAR-T cells have revolutionized the treatment of patients with refractory or relapsed hematological malignancies, and their chances of recovery, in both adults and children. Despite their clinical significance, there are limitations to producing and employing CAR-T therapies. We invite experts in the field to present new data, innovative or complementary approaches to this burning issue.

  • CELL THERAPIES

Cell therapy is a promising, rapidly advancing field with the potential to transform medicine across disease areas where significant need exists. Despite notable recent clinical and commercial successes, cell-based therapies continue to face numerous challenges that limit their widespread translation and commercialization. Presentations of cell (modified or not) therapies will be given to explore this extensive topic, which covers many therapeutic areas.

  • SECRETOMES AND EXTRACELLULAR VESICULES

Cell therapies are difficult to transport and administer. In some cases, trials have shown that the use of extracellular vesicles (EV) or the secretome can produce equally interesting effects, without the constraints of cellular therapies. EVs and secretome, the global study of molecules that are secreted by a cell, are an emerging source of new therapeutic products. After an outstanding first session in 2023, the subject will be back in the spotlight in 2024.

More infos

Back to events